To access this element change to forms mode OFF
Grant Award View - GA79774
A new radio-imaging agent to guide targeted therapy for epithelial...
GA ID:
GA79774
Agency:
Department of Health and Aged Care
Approval Date:
5-May-2020
Publish Date:
26-May-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2024
Value (AUD):
$1,893,306.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_EPCDR_Ovarian_Cancer_2020
Grant Activity:
A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer
Purpose:
We aim to revolutionise care of advanced ovarian cancer. We will further develop a new agent, 10D7, that has dual functions for diagnosing and treating ovarian cancer. We discovered and have patented this unique agent and, in this study, will label it with a radioactive particle to determine its biodistribution in patient tumours and normal organs, and its safety. The study results have significant potential to increase options for advanced ovarian cancer not responsive to current treatments.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2019 Ovarian Cancer Research Grant Opportunity
Internal Reference ID:
MRF1199422
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, QLD
Postcode:
Multiple
Country:
AUSTRALIA